| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-5793(01)03015-0 |
| P698 | PubMed publication ID | 11707268 |
| P2093 | author name string | Nagai R | |
| Yamazaki T | |||
| Zou Y | |||
| P2860 | cites work | Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors | Q73120315 |
| Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy | Q73789360 | ||
| Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries | Q74162696 | ||
| Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes | Q74583492 | ||
| Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy | Q74638195 | ||
| Regulation of mitogen-activated protein kinase cascades in the heart | Q77376158 | ||
| Signalling pathways for cardiac hypertrophy | Q77780130 | ||
| Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 | ||
| Human urotensin II mediates vasoconstriction via an increase in inositol phosphates | Q28140469 | ||
| A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 | ||
| Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study | Q29614968 | ||
| Small guanine nucleotide-binding proteins and myocardial hypertrophy | Q33927149 | ||
| Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates | Q41012086 | ||
| Mitogen-activated protein kinase (MAPK) in cardiac tissues | Q41062619 | ||
| Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase | Q41715307 | ||
| Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy | Q41845484 | ||
| Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries | Q41859635 | ||
| Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response | Q42789926 | ||
| Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase | Q43633744 | ||
| Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin | Q43660511 | ||
| Intracellular signaling pathways in cardiac myocytes induced by mechanical stress | Q47771981 | ||
| Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. | Q47928974 | ||
| Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. | Q53759460 | ||
| Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes | Q71089446 | ||
| Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy | Q71888300 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 57-60 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats | |
| P478 | volume | 508 |
| Q54708765 | Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. |
| Q37970489 | Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests |
| Q28177421 | Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure |
| Q80079843 | Enhancement of vascular smooth muscle cell migration by urotensin II |
| Q40122555 | Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease. |
| Q28208515 | Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain |
| Q24672927 | Is urotensin-II the new endothelin? |
| Q28574132 | Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium |
| Q40430686 | Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. |
| Q41122038 | Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling |
| Q43263666 | Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist |
| Q28216724 | Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure |
| Q35128456 | Potential Clinical Implications of the Urotensin II Receptor Antagonists |
| Q28241656 | The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma |
| Q40644520 | The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors |
| Q35100902 | The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems |
| Q24675590 | The role of urotensin II in cardiovascular and renal physiology and diseases |
| Q35813861 | Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway |
| Q78700092 | Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling |
| Q54534462 | Urotensin upregulates transforming growth factor-β1 expression of asthma airway through ERK-dependent pathway. |
| Q35779239 | Urotensin-II and the cardiovascular system--the importance of developing modulators |
| Q28566263 | Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators |
Search more.